Malignancy, thrombosis and Trousseau: the case for an eponym
- 15 December 2003
- journal article
- other
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (12) , 2463-2465
- https://doi.org/10.1111/j.1538-7836.2003.00501.x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Heparin Inhibition of Endothelial Cell Proliferation and Organization Is Dependent on Molecular WeightArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Armand Trousseau - Some of His Contributions to NeurologyJournal of the History of the Neurosciences, 2002
- Anticoagulants in thrombosis and cancer: the missing linkExpert Review of Anticancer Therapy, 2002
- The role of the coagulation system in tumour angiogenesisThe Lancet Oncology, 2001
- Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1999
- Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysisThe American Journal of Medicine, 1996
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- STIGLER'S LAW OF EPONYMY*Transactions of the New York Academy of Sciences, 1980
- Cancer procoagulant A: A factor X activating procoagulant from malignant tissueThrombosis Research, 1975
- PROGNOSIS IN IDIOPATHIC THOMBOPHLEBITISAnnals of Internal Medicine, 1951